- Health Tech Nerds
- Posts
- Hickpuff 10/03/2025
Hickpuff 10/03/2025
The actuarial math for ACA plans, a shutdown-induced potential cash crunch for hospitals, and MA enrollment stats
Weekly briefing
ACA Marketplaces
Uncertainty is expensive in the insurance markets
The earliest open enrollment for the individual market is in Idaho, which starts in 12 days. Most of the other marketplaces kick off their enrollment periods on November 1st. That isn’t a long time! Regardless of what happens in Washington, D.C. regarding the enhanced premium tax credits, the higher gross premiums people have been warning about if the subsidies aren’t extended are likely locked in, given the operational efforts required by the plans and their state regulators.
This doesn’t mean a deal couldn't save people money on their plans. InsideHealthPolicy is reporting that “Marketplaces in Virginia, Idaho and Georgia launched shopping tools where people can compare plans with or without the tax credits. Premiums for a 60-year-old couple making $85,000 in Virginia Beach, for example, will cost $1,295 more per month in 2026, more than triple their premium for a very similar plan this year, the group points out.”
Since the subsidies are structured as an advanced tax credit, if the deal goes through before the end of the year, people who should have paid less will get the difference refunded when they file their 2026 taxes, and it’s possible plans may be able to work something out for their members sooner. But the top line premiums, or gross price, aren’t going to change, which means in either case, taxpayers will be paying more for the subsidies than they otherwise would have next year.

Analysis
I had the chance to chat with some actuaries who work with ACA Marketplace plans, including Joe Caldwell from Evensun Health, to help me think through what this means for payers, providers, and members in 2026. My top questions were:
If the enhanced subsidies (ie, the APTCs) expire, what happens to the risk pools?
If the enhanced subsidies are renewed before the end of the year, how would that impact members and plans?
Is there any concern that the waivers for catastrophic coverage for adults over 30 will have any effect on the risk pools?
For (1), the view from Joe’s seat is that the ACA plan risk pools will be sicker than they would have been in the counterfactual where they were extended. This made intuitive sense to me, with higher prices causing some adverse selection. Not death spiral levels of adverse selection, just on the margin.
But his comment on (2) was surprising to me. Given how close we are to open enrollment, I guess it makes sense that premium rates are set. So even if Congress gets a deal together before the expiration at the end of the year, the higher premiums are locked in. Furthermore, even if the subsidies get extended, it probably won’t do much to reverse the sicker risk pool, so premiums are probably priced right in either event. If plans and states do a good job getting the word out, there may be a surprise to the upside, and 2026 could be a better-than-expected year for plans from an MLR perspective.
Finally, on (3), Joe seemed pretty skeptical about material impacts on the marketplace risk pool. The difference between a Bronze plan and a catastrophic just isn’t that large in most cases, and the administrative burdens of getting a waiver aren’t trivial. But maybe something to keep an eye on is weird stuff popping up in the catastrophic plan risk pools, since they tend to be much smaller.
This time next year, we’ll see how much all the uncertainty ended up costing us, but there’s a world where Congress’s failure to deal with the enhanced premium subsidy question in a timely manner means a more profitable year for payers on the taxpayer’s dime.
Centers for Medicare and Medicaid Services
Telehealth flexibilities lapse, and Disproportionate Share Hospital payments pause
A couple of other programs getting collateral damage from the shutdown fight are telehealth flexibilities for Medicare and Disproportionate Share Hospital (DSH) payments.
The telehealth policy is an interesting case because, rather than make permanent changes, Congress has just continued to extend pandemic-era flexibility. It expired on October 1st, and CMS has asked its contractors to take a 10-day pause before releasing reimbursements to give Congress time to make a decision. They helpfully advise providers that, without action, they are prohibited from billing for
…many services provided to beneficiaries in their homes and outside of rural areas and hospice recertifications that require a face-to-face encounter. In some cases, these restrictions can impact requirements for meeting continued eligibility for other Medicare benefits. In the absence of Congressional action, practitioners who choose to perform telehealth services that are not payable by Medicare on or after October 1, 2025, may want to evaluate providing beneficiaries with an Advance Beneficiary Notice of Noncoverage.
DSH payments are made by CMS to help hospitals cover the gap between commercial insurance rates and Medicare and Medicaid. Without congressional action, there will be an $8b cut to hospitals that provide a “disproportionate share” of care to government beneficiaries, though the timing of these payments is somewhat at the discretion of states.
Analysis
A challenge for small, independent, or otherwise lean provider and hospital groups is that these tend to be relatively low-margin businesses, so any delays or payment changes are going to impact them much more than their larger counterparts. I’m thinking about The Corvallis Clinic, which was purchased by Optum a few years back. A change to Oregon’s tax laws, the pandemic, and the Change Health data breach all compounded cashflow issues, and Optum Health stepped in as the buyer of last resort after a few other groups were scared off by the debt load.
This chart from MEDPAC gives you a sense for how important these payments are to making the math work for these hospitals:

In HCA’s 2024 annual report, they mentioned their DSH (among other) adjustments were $42m out of $70b in total revenue. They are unlikely to be too bothered by delays to these payments, but depending on how long the shutdown goes and how important telehealth reimbursement and DSH payments are to the smaller hospitals and providers, this could spark another cash crunch. If you’re in corporate development or a banker, maybe you’re starting to think through whether there’s anything strategic that could get picked up for a song.
Medicare Advantage
MA enrollment is down 2% and premiums are declining as plans focus on profitability
CMS released information on how the Medicare Advantage market is shaping up ahead of open enrollment. A few key points from their press release:
The average monthly plan premium is estimated to decrease from $16.40 in 2025 to $14.00 in 2026.
MA enrollment is expected to decrease 2% in 2026, going down to 48% compared to 50% in 2025.
Access is good at a national level, with 99% of Medicare beneficiaries having access to a plan, and 97% of Medicare beneficiaries will have access to 10 or more MA plan choices.
The total number of available MA plans nationally will decrease slightly from 5,633 in 2025 to approximately 5,600 in 2026.
This is the first year enrollment has declined in the program, at least in its current form, in what has otherwise been a consistent upward trajectory.
Analysis
HealthScape Advisors published an interesting study into regional health plans, showing the frankly pretty dire financial straits these plans find themselves in, with 71% of plans showing an annual loss in 2024.

My first thought was that the string of exits from MA markets by the national players might be a tailwind for these smaller, regional plans.
But of course, the national players are exiting markets where they aren’t able to squeeze out a reasonable profit, so there’s some selection bias when it comes to the members and regions they’re leaving.
I was chatting with Michael Bagel from America’s Community Health Plans, and he pointed out that when there’s a large influx of members into these regional plans, they need to put up regulatory reserves with the state to cover potential losses for these members. Setting aside the operational challenges of adding a bunch of members the hard-nosed, profit-seeking firms didn’t want, if you’ve been operating with negative margins for a few years, it might be hard to come up with the regulatory capital to even consider being able to take advantage of this influx.
The Hickpuff Review
Policy wonks like talking about how employer-sponsored health insurance is the U.S. system’s original sin, so I thoroughly enjoyed interviewing Russell Pekala, Yuzu’s cofounder, who makes a full-throated defense of the model.
A provision of H.R.1 allows continued Medicaid coverage for able-bodied adults if unemployment rates are high in their county.
West Virginia is worried about the President’s $100k H1B fees and how it might impact hospital staffing.
Hospitals can garnish your wages if you don’t pay in most states.
The Community Health Center Fund is also impacted by the shutdown, which comes at a uniquely bad time for FQHCs
Merger notification laws for healthcare transactions are enacted in Colorado and Washington State
CMS releases guidance for state Medicaid directors on non-citizen coverage post OBBBA
Participation in health care worker licensure compacts and use of health apps will be part of the Rural Health Transformation Program evaluative criteria for states
Can AI help deliver CMS’s value-based agenda? Michael S. Barr has some ideas in Health Affairs
Long Form: Paying for the privilege of an individual market
With the shutdown entering its third day and legislators at an impasse on how to proceed, the question of “what to do about the expiring Affordable Care Act enhanced subsidies?” is on everyone’s mind.
The basic shape of the disagreement is that the Democrats more or less unanimously insist that an extension must be part of any funding deal for the government. On the Republican side, there’s less of a consensus. There are 273 Republican legislators between the House and Senate, so this will be a little reductive, but I’m seeing two major viewpoints emerge on the question:
One group, call them Team Paragon, has the view that the best thing is to just let the enhanced subsidies expire. Ge Bai, professor at Johns Hopkins and public advisor to Paragon, wrote an op-ed in the Wall Street Journal this week making that case, and Eric Burlison, representative from the Missouri 7th congressional district, echoed the sentiment in the Washington Examiner. At a high level, their view is that the subsidies are expensive for taxpayers, unnecessary to sustain the individual market, and create the conditions for fraudulent broker activity.
Then there’s another group of Republicans who seem more interested in working something out. The dealmakers in this group have no doubt seen the polling showing consistent, overwhelming support for an extension, including a KFF poll released today, which was striking to me because I can’t think of many political issues where nearly 8 out of 10 Americans agree.

A few ideas floated by the dealmakers in the Republican caucus are income caps for the subsidies, with $200k a year being the round number on the tips of a number of tongues. Another idea is to eliminate zero-dollar premium plans to address the fraudulent enrollment problems Paragon has raised1 :

Given the dire polling on the issue, along with a quick look at enrollment by congressional district and margins of victory in the more vulnerable seats, the Paragon Institute’s hard line is making the dealmakers a bit nervous.
I think Paragon's viewpoint here is totally reasonable. The subsidies are expensive and probably contribute to some fraud, even if it’s just on the margins. If you’re a Republican with a tough race coming up next year, I think it’s also reasonable to look at the polling and say, “This would be bad for my constituents, and they don’t want it, so let’s make a deal.”
What to do about this in the next few months is a political question, and I’m not a politician, so I won’t opine. But from a policy perspective, I do think we need an answer as a country on whether we want an individual health insurance market or not. If you’re an insurance company or an investor in insurance companies, the individual market has never been all that attractive:

And Aetna decided to exit the exchanges earlier this year when people had a rosier view of the enhanced premium tax credits’ future. It’s easy to imagine a world where the ACA marketplaces became the place most people bought insurance, but that’s not the world we live in today.
Until the enhanced subsidies, the policy supports that would have helped the individual market be long-term viable and successful were largely ignored or stripped away, like the expiration of risk corridors and the functional repeal of the individual mandate. Letting the enhanced subsidies expire is another headwind for the individual market, being an attractive place to allocate capital, and it’s worth asking ourselves about whether the social utility and value of an individual market is worth the subsidies it will take to keep these markets interesting, attractive, and worth allocating capital towards because with all these headwinds, it doesn’t make a lot of sense at the moment.
1 Paragon uses plans without any claims as a proxy for fraudulent enrollees. This strikes me as a useful directional metric, but not necessarily evidence of fraud. People sign up for things all the time and never use them, even when they’re paying a lot of money for them. Consider the entire business model of gyms!
Reply